Brain stimulator in Parkinson’s disease. This image shows an implanted device that delivers electrical impulses to modulate brain activity. In this representation, the subthalamic nucleus, basal ganglia, brain, implanted electrode, and pulse generator are identified. These structures enable movement regulation and neural signal modulation.
The brain stimulator in Parkinson’s disease has a therapeutic function in controlling motor symptoms. Moreover, under normal conditions, dopamine regulates voluntary movement. Additionally, it allows smooth and coordinated execution. Furthermore, it maintains motor system balance.
On the other hand, in Parkinson’s disease, dopamine levels decrease. This alteration affects neural circuits in the basal ganglia. Moreover, it causes tremors, rigidity, and slowed movement. Additionally, motor control is disrupted.
Transport of nerve signals occurs through electrical impulses and neurotransmitters. For example, the stimulator sends signals to the subthalamic nucleus. Moreover, these signals modify abnormal neuronal activity. Additionally, they help restore functional balance.
Key processes include electrical stimulation and neural modulation. Moreover, tremors are reduced. However, muscle rigidity also improves. Additionally, motor coordination is enhanced.
Regulation depends on proper device programming. Moreover, clinical factors influence its effectiveness. Additionally, patient selection is important. Furthermore, medical follow-up is essential.
As a result, patient quality of life can significantly improve. Additionally, motor symptoms are reduced. Moreover, functional independence is enhanced.
Therefore, the brain stimulator in Parkinson’s disease is a significant technological advance. In conclusion, it modulates brain activity and improves motor control in advanced patients.